Dr Owen Tsang, medical director of the Hospital Authority’s infectious disease centre. Photo: K.Y. ChengDr Owen Tsang, medical director of the Hospital Authority’s infectious disease centre. Photo: K.Y. Cheng
Dr Owen Tsang, medical director of the Hospital Authority’s infectious disease centre. Photo: K.Y. Cheng

Hong Kong public hospitals to revise Covid-19 treatment guidelines, highlight effective drugs behind low mortality rates

  • Hospital Authority’s infectious disease expert says new guidelines will highlight Interferon as major medication, combined with Ribavirin
  • Revelation comes as city continues to register drop in new daily cases amid third wave

Topic |   Coronavirus pandemic
Dr Owen Tsang, medical director of the Hospital Authority’s infectious disease centre. Photo: K.Y. ChengDr Owen Tsang, medical director of the Hospital Authority’s infectious disease centre. Photo: K.Y. Cheng
Dr Owen Tsang, medical director of the Hospital Authority’s infectious disease centre. Photo: K.Y. Cheng
READ FULL ARTICLE
Close
We need your support

Advertising helps us continue to provide quality content. Help support us by disabling your adblocker on our site.

How to whitelist us:
  1. 1
    Click on the AdBlock icon at the top right corner of your browser.
    For iOS, go to Settings/Safari/Content Blockers and turn it off.

    For Android, go to your Ad blocker app/Settings and turn it off.
  2. 2
    Click Enabled on this site until the text reads Disabled on this site.
  3. 2
    Click the cross icon on the top right corner to close this window and refresh the page.
  4. 3
    Click the cross icon on the top right corner to close this window and refresh the page.